VIVO

Meridian Bioscience Inc
VIVO

Overview Fund Activity
Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

161 hedge funds and large institutions have $815M invested in Meridian Bioscience Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 66 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
-5
Holders Change %
-3.01%
% of All Funds
4.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
51
Reduced
66
Closed
23
Calls
$469K
Puts
$1.62M
Net Calls
-$1.15M
Net Calls Change
-$1.09M

Top Buyers

1
PIM
1
Perkins Investment Management
Illinois
$25.7M
2
Fifth Third Bancorp
2
Fifth Third Bancorp
Ohio
$9.76M
3
Norges Bank
3
Norges Bank
Norway
$11.2M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.11M
5
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$15.8M

Top Sellers

1
CI
1
Cincinnati Insurance
Ohio
$0
2
Neuberger Berman Group
2
Neuberger Berman Group
New York
$76.4M
3
CFC
3
Cincinnati Financial Corp
Ohio
$0
4
BFA
4
BlackRock Fund Advisors
California
$43.6M
5
HNB
5
Huntington National Bank
Ohio
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WSCM
176
Wellington Shields Capital Management
New York
– -$248K -11,400 Closed
AAM
177
Autus Asset Management
Arizona
– -$238K -10,923 Closed
ARTA
178
A.R.T. Advisors
New York
– -$227K -10,446 Closed
PA
179
Profund Advisors
Maryland
– -$211K -9,685 Closed
T
180
Thomaspartners
Massachusetts
– -$205K -9,430 Closed
WMSA
181
Weiss Multi-Strategy Advisers
New York
– -$204K -9,340 Closed
HR
182
Howe & Rusling
New York
– -$24K -1,096 Closed
SCG
183
Strategic Capital Group
Washington
– -$22K -1,037 Closed
TRCT
184
Tower Research Capital (TRC)
New York
– -$1K -61 Closed
4 5 6 7
8